Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial

BACKGROUND: In the multi-country PROMISE 1077BF trial, the risk of low birth weight (LBW; <2500g) and preterm delivery (PTD; <37 weeks) was higher among women initiating a protease inhibitor (PI)-based antiretroviral treatment (ART) regimen than in those receiving ZDV alone. Among those assign...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Acquir Immune Defic Syndr
Prif Awduron: Sebikari, Dorothy, Farhad, Mona, Fenton, Terry, Owor, Maxensia, Stringer, Jeffrey S. A., Qin, Min, Chakhtoura, Nahida, Chi, Benjamin H., Saidi, Friday, Nevrekar, Neetal, Violari, Avy, Chipato, Tsungai, McIntyre, James A., Moodley, Dhayendre, Taha, Taha E., Theron, Gerhard, Fowler, Mary Glenn
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6702964/
https://ncbi.nlm.nih.gov/pubmed/31295174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002072
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg